Skip to main content
Fig. 1 | BMC Veterinary Research

Fig. 1

From: Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up

Fig. 1

Reduction in monthly seizure frequency (MSF) during study phase 1. Displayed are mean ± SD of the difference in MSF prior to start of treatment (retrospective baseline) and during treatment with 1 mg/kg BID (Low dose) or 30 mg/kg BID (high dose). The MSF was significantly more reduced in the high dose group (two-sided two-sample t-test)

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us